Shock Wave Therapy + Local Vibration Beneficial for Chronic Plantar Fasciitis
By Elana Gotkine HealthDay Reporter
TUESDAY, Jan. 30, 2024 -- For patients with chronic plantar fasciitis, extracorporeal shock wave therapy combined with local vibration (ESWT-LV) is effective compared with ESWT alone, according to a study recently published in the Journal of Rehabilitation Medicine.
HyoJeong On and JongEun Yim, D.Sc., from the Graduate School of Sahmyook University in Seoul, South Korea, conducted a trial involving 34 patients (mean age, 37.5 years) with chronic plantar fasciitis who were randomly assigned to treatment with ESWT-LV or with ESWT alone. In each group, participants underwent two treatment sessions weekly for five weeks.
The researchers found that in both groups, there were significant improvements in the thickness of the plantar fascia, numerical rating scale for pain, and Foot Function Index values. Significantly greater decreases were seen in the thickness of the plantar fascia and pain in the ESWT-LV versus the ESWT-alone group. Foot Function Index values did not differ significantly between the groups.
"Based on these results, LV can be considered an effective adjunct to ESWT for plantar fasciitis," the authors write. "Further studies are necessary to determine the best parameters for LV combined with ESWT treatment in muscular skeletal disorders, in order to establish a treatment protocol."
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2024-01-31 04:15
Read more
- Prenatal Cannabis Exposure May Impact Executive Function, Behavior at Age 5 Years
- Bidirectional Link Seen for Rheumatoid Arthritis, Interstitial Lung Disease
- Duodenal ReCET Plus Semaglutide Can Prevent Need for Insulin in T2DM
- IDSA: Antibiotics for Seven Days Feasible for Patients Hospitalized With Bloodstream Infections
- Tonix Pharmaceuticals Announces Submission of the TNX-102 SL New Drug Application (NDA) for Fibromyalgia to the U.S. Food and Drug Administration (FDA)
- Orexo initiates new study of OX640 in participants with allergic rhiniti
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions